With Life-Threatening Allergies Diagnosed in Infancy, kaléo Announces Availability of First and Only FDA-Approved Epinephrine Auto-Injector (EAI) for Infants and Toddlers Weighing 16.5 to 33 Pounds (7.5 to 15 kilograms)

Thursday, April 26, 2018 Drug News
Email Print This Page Comment bookmark
Font : A-A+

AUVI-q® (epinephrine injection, USP) 0.1 mg auto-injector is specifically designed for infants and toddlers weighing 16.5 to 33 pounds (7.5 to 15 kilograms)

Like the currently available AUVI-Q (epinephrine injection, USP) 0.15 mg and 0.3 mg, AUVI-q 0.1 mg is about the size of a credit card and the thickness of a cellphone
Advertisement


Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store